Astera Labs (NASDAQ:ALAB) Price Target Raised to $389.00

Astera Labs (NASDAQ:ALAB) had its price objective hoisted by Morgan Stanley from $382.00 to $389.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock.

ALAB has been the subject of a number of other reports. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target for the company in a research report on Wednesday. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Weiss Ratings downgraded Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. TD Cowen dropped their price objective on Astera Labs from $375.00 to $300.00 and set a “hold” rating for the company in a research note on Monday, October 19th. Finally, Susquehanna reduced their target price on Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a research report on Wednesday. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $320.85.

Astera Labs Trading Up 6.3%

Shares of Astera Labs stock traded up $11.24 on Wednesday, reaching $190.71. The stock had a trading volume of 6,642,738 shares, compared to its average volume of 4,244,483. The business’s 50 day moving average is $300.46 and its two-hundred day moving average is $255.80. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48. The company has a market cap of $33.09 billion, a P/E ratio of 75.98 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.19 by $0.13. The company had revenue of $584.90 million during the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s revenue for the quarter was up 153.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.49 earnings per share. On average, equities analysts anticipate that Astera Labs will post 2.71 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the sale, the director owned 2,648 shares in the company, valued at approximately $995,806.88. This trade represents a 77.25% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. This represents a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 396,059 shares of company stock valued at $123,408,470 over the last quarter. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently added to or reduced their stakes in ALAB. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs in the second quarter worth $25,000. GK Wealth Management LLC bought a new position in shares of Astera Labs during the third quarter valued at about $29,000. Archer Investment Corp purchased a new position in shares of Astera Labs in the second quarter worth about $30,000. Signature Equity Partners LLC increased its holdings in shares of Astera Labs by 1,680.0% in the third quarter. Signature Equity Partners LLC now owns 89 shares of the company’s stock worth $32,000 after buying an additional 84 shares during the period. Finally, Whipplewood Advisors LLC increased its holdings in shares of Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after buying an additional 319 shares during the period. Institutional investors own 60.47% of the company’s stock.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported Q3 revenue of $584.9 million, up 154% year over year, and its Scorpio switch business was highlighted as a major growth driver. One Seeking Alpha contributor upgraded the stock, citing Scorpio’s momentum and gross margins that may stabilize near 72%. Astera Labs: So Much To Like In Q3 (Upgrade)
• Positive Sentiment: BMO Capital initiated coverage with an Outperform rating and a $375 price target; Northland Securities also upgraded the stock to Outperform. These calls provide a counterpoint to recent selling and valuation worries. BMO Capital Initiates Coverage on Astera Labs With Outperform Rating Astera Labs Upgraded to Outperform at Northland Securities
• Neutral Sentiment: Analyst views remain divided, with one recent opinion arguing that the selloff may already reflect a potential growth slowdown in 2027. Astera Labs: Sell-Off Already Priced In 2027 Stall
• Negative Sentiment: A reported analyst downgrade triggered renewed pressure, while coverage also points to ALAB’s rich valuation after its Q3 results. Those concerns may amplify selling when technology stocks are broadly weak. Shares Gap Down After Analyst Downgrade Stock Drops After Q3 Results Spotlight Rich Valuation
• Negative Sentiment: Astera Labs was caught in a wider technology-sector selloff, adding market-wide pressure beyond company-specific news. Astera Labs Falls Amid Tech Selloff

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.